As a group of scientists, clinicians and engineers, we began to contemplate what we could do to support a critical public health crisis from the earliest days of the pandemic. Our team moved with great urgency in collaboration with local, state, and federal agencies to develop the community-based Baseline COVID-19 Testing Program, a connected and secure solution to support individuals from screening through testing and receipt of their test results.
The Verily team, joined by volunteers from our Alphabet family, came together to stand up physical community-based testing sites, establish a complex supply chain of testing kits and personal protective equipment, and rapidly evolve our Baseline clinical trials platform to support this effort.
One year later, our program supports community testing at over 1,200 sites across 16 states. We've shared our learnings with the public since the earliest days when we released a COVID-19 Community-Based Testing Program Guide to assist other organizations with their efforts. The research side of the Baseline program is also offering insights into the evolving pandemic and supporting the understanding of treatments and vaccines.
We leveraged our experience from the Baseline testing program to help organizations across the country safely return students and employees to campus. Our Healthy at Work program has enabled 229,896 people (and counting) to return safely to their workplace or university, and Verily’s new CLIA-certified lab at our headquarters in South San Francisco received four Emergency Use Authorizations (EUAs) from the FDA for its innovation in population-based testing.
These are just a few of the initiatives Verily launched during the pandemic, and we’re excited to share the full breadth of our activities to support our communities in this report.
-Andy Conrad, CEO